Effect of intermittent inhaled tobramycin on sputum cytokine profiles in cystic fibrosis

Journal of Antimicrobial Chemotherapy

Volumn 56, Issue 1, 2005, Pages 247-249

  Husson, M O ^a   Wizla Derambure, N ^a   Turck, D ^a   Gosset, P ^a   Wallaert, B ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

IL 6; IL 8; Pseudomonas aeruginosa; TNF

Indexed keywords

CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; TOBRAMYCIN; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG EFFECT; DRUG INTERMITTENT THERAPY; GRAM NEGATIVE INFECTION; HUMAN; LEUKOCYTE COUNT; LUNG FUNCTION; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; SPUTUM ANALYSIS; IMMUNOLOGY; INHALATIONAL DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; SPUTUM;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; CYSTIC FIBROSIS; CYTOKINES; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; SPUTUM; TOBRAMYCIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 24044432285     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dki179     Document Type: Article

References (9)

1. Kammouni W, Figarella C, Marchand S [i#et al.#1i] Altered cytokine production by cystic fibrosis tracheal gland serous cells. [i#Infect Immun#1i] 1997; [b#65#1b]: 5176-83.
2. Pukhalsky AL, Kapranov NI, Kalashnikova EA [i#et al.#1i] Inflammatory markers in cystic fibrosis patients with lung [i#Pseudomonas aeruginosa#1i] infection. [i#Mediators Inflamm#1i] 1999; [b#8#1b]: 159-67.
3. Geller DE, Pitlick WH, Nardella P [i#et al.#1i] Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis. [i#Chest#1i] 2002; [b#122#1b]: 219-26.
4. Quittner A, Buu A. Effects of tobramycin solution for inhalation on global ratings of quality of life in patients with cystic fibrosis and [i#Pseudomonas aeruginosa#1i] infection. [i#Pediatr Pulmonol#1i] 2002; [b#3#1b]: 269-76.
5. Ramsey BW, Pepe MS, Quan JM [i#et al.#1i] Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic fibrosis inhaled tobramycin study group. [i#N Engl J Med#1i] 1999; [b#340#1b]: 23-30.
6. Karpati F, Hjelte FL, Wretlind B. TNF-alpha and IL-8 in consecutive sputum samples from cystic fibrosis patients during antibiotic treatment. [i#Scand J Infect Dis#1i] 2002; [b#32#1b]: 75-9.
7. Cunningham S, McColm JR, Mallinson A [i#et al.#1i] Duration of effect of intravenous antibiotics on spirometry and sputum cytokines in children with cystic fibrosis. [i#Pediatr Pulmonol#1i] 2003; [b#36#1b]: 43-8.
8. DiMango E, Zar HJ, Bryan R [i#et al.#1i] Diverse [i#Pseudomonas aeruginosa#1i] gene products stimulate respiratory epithelial cells to produce interleukin-8. [i#J Clin Invest#1i] 1995; [b#96#1b]: 2204-10.
9. DiMango E, Ratner AJ, Bryan R [i#et al.#1i] Activation of NF-kappaB by adherent [i#Pseudomonas aeruginosa#1i] in normal and cystic fibrosis respiratory epithelial cells. [i#J Clin Invest#1i] 1998; [b#101#1b]: 2598-605.